Antitumor activity of lenvatinib mesilate in human hepatocellular carcinoma preclinical models

被引：0
|
作者：
Matsuki, Masahiro
Yamamoto, Yuji
Hoshi, Taisuke
Kimura, Takayuki
Funahashi, Yasuhiro
Matsui, Junji
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1805
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1805
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Lenvatinib in combination with everolimus demonstrated enhanced antiangiogenesis and antitumor activity in human RCC xenograft models
    Adachi, Yusuke
    Matsuki, Masahiro
    Yamaguchi, Atsumi
    Ozawa, Yoichi
    Okamoto, Kiyochi
    Mitsuhashi, Kaoru
    Kimura, Takayuki
    Hoshi, Taisuke
    Tohyama, Osamu
    Tai, Kenji
    Ogo, Makoto
    Funahashi, Yasuhiro
    Matsui, Junji
    CANCER RESEARCH, 2016, 76
  • [22] Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer
    Zhang, Wen-Ji
    Li, Yong
    Wei, Meng-Ning
    Chen, Yao
    Qiu, Jian-Ge
    Jiang, Qi-Wei
    Yang, Yang
    Zheng, Di-Wei
    Qin, Wu-Ming
    Huang, Jia-Rong
    Wang, Kun
    Zhang, Wen-Juan
    Wang, Yi-Jun
    Yang, Dong-Hua
    Chen, Zhe-Sheng
    Shi, Zhi
    CANCER LETTERS, 2017, 386 : 100 - 109
  • [23] Lenvatinib: A Review in Hepatocellular Carcinoma
    Zaina T. Al-Salama
    Yahiya Y. Syed
    Lesley J. Scott
    Drugs, 2019, 79 : 665 - 674
  • [24] Lenvatinib: A Review in Hepatocellular Carcinoma
    Al-Salama, Zaina T.
    Syed, Yahiya Y.
    Scott, Lesley J.
    DRUGS, 2019, 79 (06) : 665 - 674
  • [25] Lenvatinib in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2017, 6 (04) : 253 - 263
  • [26] Resistance of Lenvatinib in Hepatocellular Carcinoma
    Guo, Jinhui
    Zhao, Junjun
    Xu, Qiuran
    Huang, Dongsheng
    CURRENT CANCER DRUG TARGETS, 2022, 22 (11) : 865 - 878
  • [27] Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism
    Yang, Chun-Cheng
    Yan, Yu-Chuan
    Pan, Guo-Qiang
    Meng, Guang-Xiao
    Zhang, Xiao
    Yan, Lun-Jie
    Ding, Zi-Niu
    Wang, Dong-Xu
    Li, Rui-Zhe
    Li, Guang-Zhen
    Dong, Zhao-Ru
    Li, Tao
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [28] Prexasertib exerts a synergistic effect on the antitumor activity of Lenvatinib through ALOX15-mediated ferroptosis in hepatocellular carcinoma
    Zhang, Shiyu
    Guan, Mingcheng
    Ren, Tianyuan
    Li, Na
    Ding, Qian
    Sun, Di
    Zhu, Hong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 150
  • [29] Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
    Giuseppa Augello
    Martina Modica
    Antonina Azzolina
    Roberto Puleio
    Giovanni Cassata
    Maria Rita Emma
    Caterina Di Sano
    Antonella Cusimano
    Giuseppe Montalto
    Melchiorre Cervello
    Cell Death & Disease, 9
  • [30] Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma
    Ito, Ryo
    Miyanishi, Koji
    Kubo, Tomohiro
    Hamaguchi, Kota
    Osuga, Takahiro
    Tanaka, Shingo
    Ohnuma, Hiroyuki
    Murase, Kazuyuki
    Takada, Kohichi
    Nagayama, Minoru
    Kimura, Yasutoshi
    Mizuguchi, Toru
    Takemasa, Ichiro
    Kato, Junji
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 735 - 744
12345